Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 55154-4384

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 55154-4384). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cardinal Health 107, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Bag Label (91bfcdf6 7fef F49b E053 2995a90ade71 00)

Bag Label (91bfcdf6 7fef F49b E053 2995a90ade71 00)
Atorvastatin Calcium Tablets 80 mg is a prescription drug sold in a bottle consisting of 6 film-coated tablets. Each tablet contains atorvastati calcium, USP equivalent to 80 mg of atorvastaty. It is manufactured in India and distributed in the US by Mylan Pharmaceuticals Inc. This drug is intended for institutional use only and is not sold in child-resistant packaging. Dosage instructions can be found in the patient information leaflet. Storage must be done between 20° to 26° C (68° to 77- ) as per USP controlled room temperature norms. The Nylan trademarks are registered to the manufacturer, while distribution is managed by Cardinal Health.*
FDA Label Image

Figure 1. Effect Of Atorvastatin Calcium 10 mg/day On Cumulative Incidence Of Nonfatal Myocardial Infarction Or Coronary Heart Disease Death (in Ascot-lla) (Ff26236c 3e07 44be A9be B619daf0ccb3 02)

Figure 1. Effect Of Atorvastatin Calcium 10 mg/day On Cumulative Incidence Of Nonfatal Myocardial Infarction Or Coronary Heart Disease Death (in Ascot-lla) (Ff26236c 3e07 44be A9be B619daf0ccb3 02)
FDA Label Image

Figure 2. Effect Of Atorvastatin Calcium 10 mg/day On Time To Occurrence Of Major Cardiovascular Event (myocardial Infarction, Acute Chd Death, Unstable Angina, Coronary Revascularization Or Stroke) I (Ff26236c 3e07 44be A9be B619daf0ccb3 03)

Figure 2. Effect Of Atorvastatin Calcium 10 mg/day On Time To Occurrence Of Major Cardiovascular Event (myocardial Infarction, Acute Chd Death, Unstable Angina, Coronary Revascularization Or Stroke) I (Ff26236c 3e07 44be A9be B619daf0ccb3 03)
FDA Label Image

Figure 3. Effect Of Atorvastatin Calcium 80 mg/day Vs. 10 mg/day On Time To Occurrence Of Major Cardiovascular Events (tnt) (Ff26236c 3e07 44be A9be B619daf0ccb3 04)

Figure 3. Effect Of Atorvastatin Calcium 80 mg/day Vs. 10 mg/day On Time To Occurrence Of Major Cardiovascular Events (tnt) (Ff26236c 3e07 44be A9be B619daf0ccb3 04)
FDA Label Image

Atorvastatin Calcium Structural Formula (Image 01)

Atorvastatin Calcium Structural Formula (Image 01)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.